Melanoma risk associated with MC1R gene variants in Latvia and the functional analysis of rare variants

Cancer Genetics

Volumn 206, Issue 3, 2013, Pages 81-91

  Ozola, Aija ^a   Azarjana, Kristine ^b   Doniņa, Simona ^c   Proboka, Guna ^c   Mandrika, Ilona ^a   Petrovska, Ramona ^a   Čema, Ingrida ^b,c   Heisele, Olita ^a   Eņģele, Ludmila ^c   Štreinerte, Baiba ^c   Pjanova, Dace ^a  

^a LATVIAN BIOMEDICAL RESEARCH AND STUDY CENTRE   (Latvia)

^b RIGA STRADINS UNIVERSITY   (Latvia)

^c RIGA EAST UNIVERSITY HOSPITAL   (Latvia)

Author keywords

Functionality of MC1R variants; Melanocortin 1 receptor gene; Melanoma; Pigmentation; Rare MC1R variants

Indexed keywords

MELANOCORTIN 1 RECEPTOR;

ANIMAL CELL; ARTICLE; CANCER RISK; CONTROLLED STUDY; EYE COLOR; FEMALE; GENE DOSAGE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HAIR COLOR; HUMAN; LATVIA; LENTIGO; MAJOR CLINICAL STUDY; MALE; MC1R GENE; MELANOMA; NEVUS; NONHUMAN; ONCOGENE; ONSET AGE; PHENOTYPE; PIGMENTATION; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SKIN COLOR; SKIN STRUCTURE;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CELL LINE; CELL MEMBRANE; CYCLIC AMP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GREEN FLUORESCENT PROTEINS; HUMANS; LATVIA; LINKAGE DISEQUILIBRIUM; MALE; MELANOMA; MICROSCOPY, CONFOCAL; MIDDLE AGED; MUTATION, MISSENSE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, MELANOCORTIN, TYPE 1; RISK FACTORS; SKIN NEOPLASMS;

EID: 84875919837     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2013.01.002     Document Type: Article

References (45)

1. MacKie R.M., Hauschild A., Eggermont A.M. Epidemiology of invasive cutaneous melanoma. Ann Oncol 2009, 20:1-7.
2. Miller A.J., Mihm M.C. Melanoma. N Engl J Med 2006, 355:51-65.
3. Bataille V. Genetic epidemiology of melanoma. Eur J Cancer 2003, 39:1341-1347.
4. Florell S.R., Boucher K.M., Garibotti G., et al. Population-based analysis of prognostic factors and survival in familial melanoma. J Clin Oncol 2005, 23:7168-7177.
5. Cannon-Albright L.A., Goldgar D.E., Meyer L.J., et al. Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science 1992, 258:1148-1152.
6. Zuo L., Weger J., Yang Q., et al. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat Genet 1996, 12:97-99.
7. Goldstein A.M., Chan M., Harland M., et al. Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents. J Med Genet 2007, 44:99-106.
8. Orlow I., Begg C.B., Cotignola J., et al. CDKN2A germline mutations in individuals with cutaneous malignant melanoma. J Invest Dermatol 2007, 127:1234-1243.
9. Chatzinasiou F., Lill C.M., Kypreou K., et al. Comprehensive field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma. J Natl Cancer Inst 2011, 103:1227-1235.
10. Palmer J.S., Duffy D.L., Box N.F., et al. Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype?. Am J Hum Genet 2000, 66:176-186.
11. Hunt G., Kyne S., Wakamatsu K., et al. Nle4DPhe7 alpha-melanocyte-stimulating hormone increases the eumelanin: phaeomelanin ratio in cultured human melanocytes. J Invest Dermatol 1995, 104:83-85.
12. Pérez Oliva A.B., Fernéndez L.P., Detorre C., et al. Identification and functional analysis of novel variants of the human melanocortin 1 receptor found in melanoma patients. Hum Mutat 2009, 30:811-822.
13. Duffy D.L., Box N.F., Chen W., et al. Interactive effects of MC1R and OCA2 on melanoma risk phenotypes. Hum Mol Genet 2004, 13:447-461.
14. Flanagan N., Healy E., Ray A., et al. Pleiotropic effects of the melanocortin 1 receptor (MC1R) gene on human pigmentation. Hum Mol Genet 2000, 9:2531-2537.
15. Williams P.F., Olsen C.M., Hayward N.K., et al. Melanocortin 1 receptor and risk of cutaneous melanoma: a meta-analysis and estimates of population burden. Int J Cancer 2011, 129:1730-1740.
16. Kanetsky P.A., Panossian S., Elder D.E., et al. Does MC1R genotype convey information about melanoma risk beyond risk phenotypes?. Cancer 2010, 116:2416-2428.
17. Beaumont K.A., Shekar S.N., Newton R.A., et al. Receptor function, dominant negative activity and phenotype correlations for MC1R variant alleles. Hum Mol Genet 2007, 16:2249-2260.
18. Newton R.A., Smit S.E., Barnes C.C., et al. Activation of the cAMP pathway by variant human MC1R alleles expressed in HEK and in melanoma cells. Peptides 2005, 26:1818-1824.
19. Ringholm A., Klovins J., Rudzish R., et al. Pharmacological characterization of loss of function mutations of the human melanocortin 1 receptor that are associated with red hair. J Invest Dermatol 2004, 123:917-923.
20. Schiöth H.B., Phillips S.R., Rudzish R., et al. Loss of function mutations of the human melanocortin 1 receptor are common and are associated with red hair. Biochem Biophys Res Commun 1999, 260:488-491.
21. Beaumont K.A., Newton R.A., Smit D.J., et al. Altered cell surface expression of human MC1R variant receptor alleles associated with red hair and skin cancer risk. Hum Mol Genet 2005, 14:2145-2154.
22. Ho S.N., Hunt H.D., Horton R.M., et al. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 1989, 77:51-59.
23. Hinkle P.M., Sebag J.A. Structure and function of the melanocortin2 receptor accessory protein (MRAP). Mol Cell Endocrinol 2009, 300:25-31.
24. Fridmanis D., Petrovska R., Kalnina I., et al. Identification of domains responsible for specific membrane transport and ligand specificity of the ACTH receptor (MC2R). Mol Cell Endocrinol 2010, 321:175-183.
25. Purcell S., Neale B., Todd-Brown K., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007, 81:559-575.
26. Raimondi S., Sera F., Gandini S., et al. MC1R variants, melanoma and red hair color phenotype: a meta-analysis. Int J Cancer 2008, 122:2753-2760.
27. Adzhubei I.A., Schmidt S., Peshkin L., et al. A method and server for predicting damaging missense mutations. Nat Methods 2010, 7:248-249.
28. Saeed A.I., Sharov V., White J., et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 2003, 34:374-378.
29. Gerstenblith M.R., Goldstein A.M., Fargnoli M.C., et al. Comprehensive evaluation of allele frequency differences of MC1R variants across populations. Hum Mutat 2007, 28:495-505.
30. Galore-Haskel G., Azizi E., Mohamdi H., et al. MC1R variant alleles and malignant melanoma risk in Israel. Eur J Cancer 2009, 45:2015-2022.
31. Kennedy C., ter Huurne J., Berkhout M., et al. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol 2001, 117:294-300.
32. Landi M.T., Kanetsky P.A., Tsang S., et al. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. J Natl Cancer Inst 2005, 97:998-1007.
33. Matichard E., Verpillat P., Meziani R., et al. Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure. J Med Genet 2004, 41:e13.
34. Scherer D., Nagore E., Bermejo J.L., et al. Melanocortin receptor 1 variants and melanoma risk: a study of 2 European populations. Int J Cancer 2009, 125:1868-1875.
35. Stratigos A.J., Dimisianos G., Nikolaou V., et al. Melanocortin receptor-1 gene polymorphisms and the risk of cutaneous melanoma in a low-risk southern European population. J Invest Dermatol 2006, 126:1842-1849.
36. Scott M.C., Wakamatsu K., Ito S., et al. Human melanocortin 1 receptor variants, receptor function and melanocyte response to UV radiation. J Cell Sci 2002, 115:2349-2355.
37. Davies J.R., Randerson-Moor J., Kukalizch K., et al. Inherited variants in the MC1R gene and survival from cutaneous melanoma: a BioGenoMEL study. Pigment Cell Melanoma Res 2012, 25:384-394.
38. García-Borrón J.C., Sánchez-Laorden B.L., Jiménez-Cervantes C. Melanocortin-1 receptor structure and functional regulation. Pigment Cell Res 2005, 18:393-410.
39. Jiménez-Cervantes C., Olivares C., González P., et al. The Pro162 variant is a loss-of-function mutation of the human melanocortin 1 receptor gene. J Invest Dermatol 2001, 117:156-158.
40. Nakayama K., Soemantri A., Jin F., et al. Identification of novel functional variants of the melanocortin 1 receptor gene originated from Asians. Hum Genet 2006, 119:322-330.
41. Sánchez Más J., Olivares Sánchez C., Ghanem G., et al. Loss-of-function variants of the human melanocortin-1 receptor gene in melanoma cells define structural determinants of receptor function. Eur J Biochem 2002, 269:6133-6141.
42. Prusis P., Schiöth H.B., Muceniece R., et al. Modeling of the three-dimensional structure of the human melanocortin 1 receptor, using an automated method and docking of a rigid cyclic melanocyte-stimulating hormone core peptide. J Mol Graph Model 1997, 15:307-317. 334.
43. Yang Y., Dickinson C., Haskell-Luevano C., et al. Molecular basis for the interaction of [Nle4, D-Phe7]melanocyte stimulating hormone with the human melanocortin-1 receptor. J Biol Chem 1997, 272:23000-23010.
44. Robinson S.J., Healy E. Human melanocortin 1 receptor (MC1R) gene variants alter melanoma cell growth and adhesion to extracellular matrix. Oncogene 2002, 21:8037-8046.
45. Maaser C., Kannengiesser K., Specht C., et al. Crucial role of the melanocortin receptor MC1R in experimental colitis. Gut 2006, 55:1415-1422.